The use of Paclitaxel on a chemotherapeutic regimen has been shown to have minimal effect on [18F]FLT uptake, since it induces cell cycle arrest in an advanced point which doesn’t affect TK1 expression or change cell proliferation, even though it reduces tumor growth [22]. The gene discussed is TK1; the disease is neoplasm.